Prolonged Sleep Apnea in Two Patients with a History of Opium Abuse-A Case Report

Document Type : Case Report

Authors

1 Fellowship of Sleep Medicine, Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

2 Psychiatrist, Sleep Clinic of Ebn-e-Sina Hospital, Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

3 Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran, and Department of Pharmacology, Medical University Innsbruck, Innsbruck, Austria.

4 Department of Medicine at Baylor College of Medicine, VAMC Sleep Center, Houston, TX.

5 Occupational Medicine, Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

6 Department of Neurological Diseases, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

7 Lung Disease Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Abstract

Introduction:
Obstructive sleep apnea (OSA) is a highly prevalent sleep-disordered breathing (SDB).
 
Case Report:
Two 53- and 51-year-old male cases with daytime sleepiness and opium abuse and severe sleep apnea and long respiratory events duration (200 and 275 seconds respectively) noted in polysomnography were reported at Ebn-e-Sina and Razavi hospitals, in Mashhad, Iran. After positive airway pressure (PAP) therapy respiratory events resolved and patients’ daytime alertness improved. 
 
Conclusion:
The long duration of sleep apnea could be the result of opium abuse. Therefore, drug history should be carefully considered in the evaluation of SDB patients. The PAP device was effective in the management of sleep respiratory events and the improvement of patient’s complications
 

Keywords

References

  1.  

    1. Guven SF, Dursun AB, Ciftci B, Erkekol FO, Kurt OK. The prevalence of obstructive sleep apnea in patients with difficult-to-treat asthma. Asian Pac J Allergy Immunol 2014; 32(2):153–9.
    2. Kielb SA, Ancoli-Israel S, Rebok GW, Spira AP. Cognition in obstructive sleep apnea-hypopnea syndrome (OSAS): current clinical knowledge and the impact of treatment. Neuromolecular Med 2012; 14(3):180–93.
    3. Ruehland WR, Rochford PD, O'Donoghue FJ, Pierce RJ, Singh P, Thornton AT. "The new AASM criteria for scoring hypopneas: impact on the apnea hypopnea index". [sleep] 2009; 32(2):150–7.
    4. Harvard Medical School. "Understanding the Results: Sleep Apnea". Harvard University; 5 septemner 2014 5 septemner 2014.
    5. Mediano O, Barcelo A, La Pena M de, Gozal D, Agusti A, Barbe F. Daytime sleepiness and polysomnographic variables in sleep apnoea patients. Eur Respir J 2007; 30(1):110–3.
    6. Richard B. Berry, Charlene E. Gamaldo, Susan M. Harding, Rita Brooks, Robin M. Lloyd, Bradley V. Vaughn. AASM Scoring Manual Version 2.2 Updates: New Chapters for Scoring Infant Sleep Staging and Home Sleep Apnea Testing. Available from: URL: J Clin Sleep Med. 2015 Nov 15; 11(11):1253–4.
    7. Aulakh PK, Westerman DE, Dedhia RC. The Longest Obstructive Apnea You Have Ever Seen: A Patient With New-Onset Autonomic Dysfunction. J Clin Sleep Med 2018; 14(5):893–5.
    8. Chowdhuri S, Javaheri S. Sleep Disordered Breathing Caused by Chronic Opioid Use: Diverse Manifestations and Their Management. Sleep Med Clin 2017; 12(4):573–86.
    9. Sharkey KM, Kurth ME, Anderson BJ, Corso RP, Millman RP, Stein MD. Obstructive sleep apnea is more common than central sleep apnea in methadone maintenance patients with subjective sleep complaints. Drug Alcohol Depend 2010; 108(1-2):77–83.
    10. Lurie A. Cardiovascular disorders associated with obstructive sleep apnea. Adv Cardiol 2011; 46:197–266.
Iranian Journal of Otorhinolaryngology
Volume 32, Issue 2
March and April 2020
Pages 127-131

Files

Share

How to cite

Statistics